Table 1. Protocol for evaluation of the hepatoprotective activity.
Group Number | Group Status | Treatment Specimen | The volume of Treatment specimen (mg/kg) | Group Abbreviation |
---|---|---|---|---|
1 | Negative Control | Physiological Saline | 10mL/kg | C |
2 | Disease control | Carbon tetra chloride (CCl4) | 3mL/kg | CCl4 |
3 | CCl4 + Silymarin | Silymarin | 3mL/kg+80mg/kg | CCl4+S80 |
4 | CCl4 + Silymarin | Silymarin | 3mL/kg+120mg/kg | CCl4+S120 |
5 | CCl4 + Silymarin | Silymarin | 3mL/kg+150mg/kg | CCl4+S150 |
6 | CCl4 + Gynura procumbens | Gynura Procumbens | 3mL/kg+500mg/kg | CCl4+GP500 |
7 | CCl4 + Gynura procumbens | Gynura Procumbens | 3mL/kg+750mg/kg | CCl4+GP750 |
8 | CCl4 + Gynura procumbens | Gynura Procumbens | 3mL/kg+1000mg/kg | CCl4+GP1000 |
9 | Silymarin | Silymarin | 80mg/kg | S80 |
10 | Silymarin | Silymarin | 120mg/kg | S120 |
11 | Silymarin | Silymarin | 150mg/kg | S150 |
12 | Gynura procumbens | Gynura Procumbens | 500mg/kg | GP500 |
13 | Gynura procumbens | Gynura Procumbens | 750mg/kg | GP750 |
14 | Gynura procumbens | Gynura Procumbens | 1000mg/kg | GP1000 |